An investigation on behalf of investors of Kindred Healthcare, Inc. (NYSE:KND) in connection with the proposed takeover was announced and NYSE:KND stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 01/02/2018 --An investigation was announced on behalf of investors of shares of Kindred Healthcare, Inc. (NYSE:KND) concerning whether the takeover of Kindred Healthcare, Inc. is unfair.

Investors who purchased shares of Kindred Healthcare, Inc. (NYSE:KND) and currently hold any of those NYSE:KND shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain directors of Kindred Healthcare, Inc. breached their fiduciary duties owed to NYSE:KND investors in connection with the proposed acquisition.

On Dec. 19, 2017, Kindred Healthcare, Inc. (NYSE:KND) announced that its Board of Directors has approved an agreement under which it will be acquired by a consortium of three companies: TPG Capital ("TPG"), Welsh, Carson, Anderson & Stowe ("WCAS") and Humana Inc. ("Humana") (NYSE: HUM) (together, the "consortium") for approximately $4.1 billion in cash including the assumption or repayment of net debt.

Under the terms of the agreement, Kindred Healthcare, Inc. (NYSE:KND) stockholders will receive $9.00 in cash for each share of Kindred common stock they hold.

However, given that at least one analyst has set the high price target ofr NYSE:KND shares at $11.00 per share and given that NYSE:KND shares traded in the open market as recently as June 2017 as high as $11.65 per share, the investigation concerns whether the offer is unfair to NYSE:KND stockholders. More specifically, the investigation concerns whether the Kindred Healthcare Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

On December 29, 2017, NYSE:KND shares closed at $9.70 per share.

Those who are current investors in Kindred Healthcare, Inc. (NYSE:KND) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com